CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- 4 Shares withheld for taxes CFO & COO gave up 33 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CMO gave up 33 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes EVP, CMO gave up 408 shares (to pay taxes)
- 4 Shares withheld for taxes CFO & COO gave up 408 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 47,182 shares at an average $2.86 ($134,821)
- 4 Open-market sale 10% owner sold 264,963 shares at an average $3.16 ($837,467)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chairman & CEO bought 17,500 shares at $3.61 ($63,093)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 24 · 465 filings